All In Biotech

Free tool

FAERS Monitor: Cystadane

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020576 or its brand name (Cystadane, Betaine). Reports on generic versions are filed under their own applications.

Reports

1,045

Serious

656

63% of reports

Hospitalization

400

Death reported

74

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use149
  • overdose86
  • vomiting81
  • diarrhoea64
  • product dose omission55
  • nausea48
  • seizure43
  • product use issue41
  • pneumonia39
  • product dose omission issue39
  • pyrexia39
  • inappropriate schedule of product administration37
  • influenza35
  • abdominal discomfort31
  • treatment noncompliance30

Reports by year received

View as table
YearReports
20042
20052
20062
20084
20093
20105
20118
201224
201314
201435
201539
201685
201772
201883
2019122
2020123
202165
202284
2023118
202464
202560
202631

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,114 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
product dose omissionSignal5517.013.1813
treatment noncomplianceSignal3011.07.8265
overdoseSignal868.06.6527
seizureSignal437.55.6237
influenzaSignal356.34.6152
product use issueSignal414.43.3105
inappropriate schedule of product administrationSignal374.13.085
abdominal discomfortSignal313.72.659
vomitingSignal813.52.8143
off label useSignal1493.43.0264
product dose omission issueSignal392.72.040
pneumoniaSignal392.41.832
pyrexiaSignal392.31.727
diarrhoea642.01.632
nausea481.20.92

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.